SearchDictionaryMobileLogin

Ian G McKeith Selected Research

Dementia (Dementias)

11/2007Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline.
10/2007Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies.
01/2007Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies.
11/2006In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia.
08/2006Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation.
08/2006Cholinesterase inhibitors in advanced Dementia with Lewy bodies: increase or stop?
10/2005A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.
10/2005Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.
11/2004The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease.
09/2004Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies.
06/2004Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
01/2004Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies.
04/2003Regulation of attention and response to therapy in dementia by butyrylcholinesterase.
01/2002Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies.

Articles by Research Topic

Disease

14Dementia (Dementias)
11/2007 - 01/2002
7Parkinson Disease (Parkinson's Disease)
01/2007 - 09/2004
5Alzheimer Disease (Alzheimer's Disease)
10/2007 - 11/2004
1Lewy Body Disease (Lewy Body Dementia)
02/2006
1Hallucinations (Hallucination)
01/2004

Drug/Important Bio-Agent (IBA)

42- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
10/2007 - 06/2004
2Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
07/2007 - 11/2006
2donepezil (Aricept)FDA LinkGeneric
01/2007 - 10/2005
2Cholinesterase Inhibitors (Anticholinesterases)IBA
08/2006 - 09/2004
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
11/2007
1Cholinesterases (Cholinesterase)IBA
10/2007
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
08/2006
1SynucleinsIBA
02/2006
1Insulysin (Insulin-Degrading Enzyme)IBA
07/2005
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
06/2004
1rivastigmine (Exelon)FDA LinkGeneric
01/2004
1ButyrylcholinesteraseIBA
04/2003
1ApolipoproteinsIBA
01/2002